Edastuskiri
| Dokumendiregister | Terviseamet |
| Viit | 8-2/25/7073-1 |
| Registreeritud | 11.09.2025 |
| Sünkroonitud | 12.09.2025 |
| Liik | Sissetulev dokument |
| Funktsioon | 8 Nakkushaiguste seire, ennetuse ja tõrje korraldamine |
| Sari | 8-2 Nakkushaiguste epidemioloogiaalane riigiväline kirjavahetus |
| Toimik | 8-2/2025 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | ECDC respiratory viruses |
| Saabumis/saatmisviis | ECDC respiratory viruses |
| Vastutaja | Erika Poots |
| Originaal | Ava uues aknas |
Failid
|
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
To: National Focal Points for Viral Respiratory Diseases, Operational Contact Points for influenza, Covid -19 and SARI (microbiology)
Cc: National Coordinators
Dear Network Members,
The European Commission has launched an open consultation to gather feedback on the targeted revision of EU rules for medical devices and in vitro diagnostics (MDR/IVDR). This initiative aims to simplify the regulatory framework while maintaining high standards of patient safety and public health.
The consultation is open from 8 September to 6 October 2025, and your input is highly valued. Feedback from stakeholders is critical to ensure that future regulatory changes are informed, balanced, and responsive to real-world challenges.
We strongly encourage you to contribute your perspectives to help shape the next phase of EU medical device regulation.
Medical devices and in vitro diagnostics – targeted revision of EU rules
Kind Regards,
The ECDC Respiratory Viruses Team
|
|||||||||||||||||||||
|
|
Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly requested, to, consecutively, refrain from disclosing its content to any third party, delete it and inform its sender of the erroneous transmittal.
